WallStreetZenWallStreetZen

NASDAQ: BDSX
Biodesix Inc Stock Forecast, Predictions & Price Target

Analyst price target for BDSX

Based on 1 analyst offering 12 month price targets for Biodesix Inc.
Min Forecast
$3.50+177.78%
Avg Forecast
$3.50+177.78%
Max Forecast
$3.50+177.78%

Should I buy or sell BDSX stock?

Based on 1 analyst offering ratings for Biodesix Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BDSX stock forecasts and price targets.

BDSX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-04

1 of 1

Forecast return on equity

Is BDSX forecast to generate an efficient return?
Company
N/A
Industry
8.17%
Market
29.75%

Forecast return on assets

Is BDSX forecast to generate an efficient return on assets?
Company
N/A
Industry
3.18%

BDSX revenue forecast

What is BDSX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$65.0M+32.42%
Avg 2 year Forecast
$75.6M+54.01%
BDSX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BDSX revenue growth forecast

How is BDSX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
32.42%
Industry
3.74%
Market
13.23%
BDSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BDSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BDSX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
BDSX$1.26$3.50+177.78%Strong Buy
NOTV$4.67$18.25+290.79%Strong Buy
STIM$3.75$8.00+113.33%Strong Buy
FONR$16.19N/AN/A
PRPH$5.06$11.00+117.39%Buy

Biodesix Stock Forecast FAQ

Is Biodesix Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BDSX) stock is to Strong Buy BDSX stock.

Out of 1 analyst, 1 (100%) are recommending BDSX as a Strong Buy, 0 (0%) are recommending BDSX as a Buy, 0 (0%) are recommending BDSX as a Hold, 0 (0%) are recommending BDSX as a Sell, and 0 (0%) are recommending BDSX as a Strong Sell.

If you're new to stock investing, here's how to buy Biodesix stock.

What is BDSX's revenue growth forecast for 2024-2025?

(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 32.42% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.

Biodesix's revenue in 2024 is $49,087,000.On average, 1 Wall Street analysts forecast BDSX's revenue for 2024 to be $6,301,233,965, with the lowest BDSX revenue forecast at $6,301,233,965, and the highest BDSX revenue forecast at $6,301,233,965.

In 2025, BDSX is forecast to generate $7,328,819,812 in revenue, with the lowest revenue forecast at $7,328,819,812 and the highest revenue forecast at $7,328,819,812.

What is BDSX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: BDSX) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.18%.

What is BDSX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BDSX price target, the average BDSX price target is $3.50, with the highest BDSX stock price forecast at $3.50 and the lowest BDSX stock price forecast at $3.50.

The Wall Street analyst predicted that Biodesix's share price could reach $3.50 by Mar 4, 2025. The average Biodesix stock price prediction forecasts a potential upside of 177.78% from the current BDSX share price of $1.26.

What is BDSX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: BDSX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.